Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5...

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Fragile X syndrome (FXS), the leading inherited intellectual disability, results from the loss of fragile X mental retardation protein (FMRP).
• The precise impact of FMRP loss on astroglial function and protein expression is largely unknown.
• Astroglia play critical roles in neuron communication and brain development.

Purpose of the Study:

• To investigate how the absence of FMRP in astrocytes affects cellular function and molecular pathways.
• To identify specific molecular mechanisms, including microRNAs (miRNAs), involved in FXS pathogenesis within astroglia.
• To elucidate the role of astroglial metabotropic glutamate receptor 5 (mGluR5) signaling in FMRP deficiency.

Main Methods:

• Selective in vivo deletion of FMRP in mouse and human astroglia.
• Quantitative real-time PCR to measure miRNA expression (miR-128-3p).
• Western blotting and functional assays to assess mGluR5 expression and signaling.
• Transcriptome and proteome profiling.
• In vivo inhibition and overexpression of miR-128-3p in FMRP-deficient astroglia.

Main Results:

• Selective loss of astroglial FMRP up-regulates miR-128-3p in both mouse and human cells.
• miR-128-3p suppresses the developmental expression of astroglial mGluR5.
• Inhibition of miR-128-3p rescues mGluR5 function in FMRP-deficient astroglia.
• FMRP primarily regulates protein expression via posttranscriptional mechanisms in astroglia.
• Astroglial overexpression of miR-128-3p selectively diminishes mGluR5 signaling.

Conclusions:

• A novel FMRP-dependent, cell-autonomous miRNA pathway involving miR-128-3p in astroglia is identified.
• This pathway selectively modulates developmental astroglial mGluR5 signaling, contributing to FXS pathogenesis.
• The study uncovers crucial astroglial molecular mechanisms underlying fragile X syndrome.